Type 2 diabetes mellitus (T2DM) is a global medical problem. While Continuous
Energy Restriction (CER) is the standard dietary intervention, it is frequently
impeded by poor long-term adherence. Intermittent-Fasting (IF) and Time-
Restricted Eating are subtypes of Intermittent-Fasting regimens. These interventions
try to align food intake with the circadian rhythm of the pancreatic beta cells. The
aim of this review is to reevaluate the effectiveness and safety of IF, with an
emphasis on Time-Restricted Eating as an adjunctive therapy for T2DM. Our study
will focus on reviewing the papers published between 2020 and 2025. We have
mainly analyzed randomized controlled trials. We tried to emphasize the difference
between IF and broader fasting protocols, with the main difference being the
alignment of calorie intake with the circadian rhythm. Recent RCTs indicate that IF
and TRE improve glycemic control and are responsible for weight loss. The effects
are comparable to those of the Continuous Energy Restriction Diet. Time-restricted
eating seems to represent a safe and effective therapeutic strategy for T2DM. It
offers synergistic benefits when combined with exercise and might facilitate the
reduction of pharmacological treatment. The mechanisms of time-restricted eating
differ from those of CRE. According to Harris and Czaja, aligning caloric intake
with the circadian rhythm promotes "beta-cell rest," which is an effect that reduces
the secretory demand on beta-cells. The advantage of time-restricted eating over
calorie-restricting diets lies in glycemic stability. It significantly improves “Time in
Range” (TIR). Weight loss is a secondary result of unintentional calorie reduction.
Keywords: Type 2 diabetes, Time-restricted eating, Intermittent fasting, Circadian
rhythm, Glycemic Control
